MYGN - Myriad Genetics collaborates with GSK for HRD testing in 9 countries
2024-06-11 08:38:35 ET
More on Myriad Genetics
- Myriad Genetics, Inc. (MYGN) Q1 2024 Earnings Call Transcript
- Myriad Genetics surges 17% as Street applauds 2024 guidance, Q1 results
- Myriad Genetics GAAP EPS of -$0.29 beats by $0.01, revenue of $202.2M beats by $8.95M
- Seeking Alpha’s Quant Rating on Myriad Genetics
- Historical earnings data for Myriad Genetics